Oncolytics Biotech Stock Alpha and Beta Analysis
| ONC Stock | CAD 1.32 0.06 4.35% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Oncolytics Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Oncolytics Biotech over a specified time horizon. Remember, high Oncolytics Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Oncolytics Biotech's market risk premium analysis include:
Beta (1.01) | Alpha 0.28 | Risk 5.35 | Sharpe Ratio 0.0332 | Expected Return 0.18 |
Oncolytics Biotech Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Oncolytics |
Oncolytics Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Oncolytics Biotech market risk premium is the additional return an investor will receive from holding Oncolytics Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Oncolytics Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Oncolytics Biotech's performance over market.| α | 0.28 | β | -1.01 |
Oncolytics Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Oncolytics Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Oncolytics Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Oncolytics Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Oncolytics Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncolytics Biotech shares will generate the highest return on investment. By understating and applying Oncolytics Biotech stock market price indicators, traders can identify Oncolytics Biotech position entry and exit signals to maximize returns.
Oncolytics Biotech Return and Market Media
The median price of Oncolytics Biotech for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 is 1.38 with a coefficient of variation of 13.83. The daily time series for the period is distributed with a sample standard deviation of 0.2, arithmetic mean of 1.45, and mean deviation of 0.18. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Investors Watch Key Players in Oncology as Cancer Cases Set to Skyrocket - Baystreet.ca | 09/20/2024 |
2 | Stocks In Play Oncolytics Biotech Inc - Barchart | 11/11/2024 |
About Oncolytics Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Oncolytics or other stocks. Alpha measures the amount that position in Oncolytics Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Net Debt To EBITDA | 1.02 | 1.52 | Intangibles To Total Assets | 0.0149 | 0.0141 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oncolytics Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oncolytics Biotech's short interest history, or implied volatility extrapolated from Oncolytics Biotech options trading.
Build Portfolio with Oncolytics Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Oncolytics Biotech Backtesting, Oncolytics Biotech Valuation, Oncolytics Biotech Correlation, Oncolytics Biotech Hype Analysis, Oncolytics Biotech Volatility, Oncolytics Biotech History and analyze Oncolytics Biotech Performance. To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Oncolytics Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.